1. Home
  2. AXS vs RGEN Comparison

AXS vs RGEN Comparison

Compare AXS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axis Capital Holdings Limited

AXS

Axis Capital Holdings Limited

N/A

Current Price

$106.84

Market Cap

7.4B

Sector

Finance

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$157.74

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXS
RGEN
Founded
2001
1981
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AXS
RGEN
Price
$106.84
$157.74
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
$117.00
$174.90
AVG Volume (30 Days)
599.1K
671.3K
Earning Date
01-28-2026
10-28-2025
Dividend Yield
1.64%
N/A
EPS Growth
68.27
N/A
EPS
12.10
0.03
Revenue
$6,301,015,000.00
$707,890,000.00
Revenue This Year
$6.62
$17.84
Revenue Next Year
$8.64
$12.57
P/E Ratio
$8.85
$6,212.76
Revenue Growth
5.59
11.74
52 Week Low
$83.90
$102.97
52 Week High
$108.12
$182.52

Technical Indicators

Market Signals
Indicator
AXS
RGEN
Relative Strength Index (RSI) 71.97 47.22
Support Level $97.16 $156.01
Resistance Level $108.12 $165.02
Average True Range (ATR) 1.92 4.67
MACD 0.63 -1.45
Stochastic Oscillator 91.97 7.25

Price Performance

Historical Comparison
AXS
RGEN

About AXS Axis Capital Holdings Limited

Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: